Abivax (ABVX) is scheduled to report H1 earnings on August 10, 2026. Analysts estimate EPS of $-0.75 and quarterly revenue of $2.29M.
In the most recent quarter (FY), Abivax reported EPS of $-5.45, missing estimates of $-4.91 by 0.11%. Revenue came in at $5.16M, missing the estimate of $5.51M by 0.06%.
Abivax has missed EPS estimates in 3 consecutive quarters.
Over the last 3 quarters, Abivax has averaged an EPS surprise of 0.43% and a revenue surprise of 1.61%.
Analyze the earnings history of Abivax using advanced sorting and filters.
The chart below shows Abivax's reported EPS compared to analyst estimates over recent quarters.
The chart below shows Abivax's reported revenue compared to analyst estimates over recent quarters.
Abivax (ABVX) is scheduled to report earnings on August 10, 2026. The last reported earnings were for reported on March 23, 2026 for FY.
The Actual EPS was $-5.45, which missed the estimate of $-4.91.
The Actual Revenue was $5.16M, which missed the estimate of $5.51M.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| FY | 2026-03-23 | $-5.45 | $-4.91 | -11.0 % |
| H1 | 2025-08-11 | $-1.47 | $-0.90 | -63.3 % |
| FY | 2024-04-02 | $-3.71 | $-2.38 | -55.9 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| FY | 2026-03-23 | $5.16M | $5.51M | -6.32 % |
| H1 | 2025-08-11 | $7.73M | $1.35M | 472.4 % |
| FY | 2024-04-02 | $5.00M | $4.76M | 5.04 % |